Apnea-Tech Ltd is a health start-up company based in the Northwest of England. We have developed a simple, low-cost screening device that accurately captures sleep disorder events. The device is MHRA registered and UKCA accredited.
There are over 1 Billion people worldwide with Sleep related Breathing Disorders
Only 20% are diagnosed
The problem space
About 90% of people with sleep apnoea have Obstructive Sleep Apnoea (OSA), which is a chronic condition characterised by frequent upper airway collapse during sleep, leading to co-morbidities such as systemic hypertension, cardiovascular disease, stroke, and abnormal glucose metabolism, all of which impose a significant health economic burden.
An accessible screening device is crucial to properly identify people with Sleep-related Breathing Disorders.
The solution
The ApneScan-DC1 is a purposeful, low-cost Sleep-Related Breathing Disorders screening device, MHRA registered and UKCA accredited.
- Simple, Lightweight wearable device
- Records actual events in the breath pathway
- Data is analysed using Model-Driven Engineering techniques to identify events
- The device is low cost, disposable and environmentally friendly
- MHRA registered
- First NHS use demonstrated 95.5% correlation with Gold Standard (Thorax Dec 2025)
- Designed for Market Manufacture (TRL7) in collaboration with Innovate UK, Med-Tech Catapult (Singapore), STFC, Keele University and University Hospitals of North Midlands
Sleep Apnoea stratification made simple
Andy Moss
CEO & Founder, Director
30 years + in Healthcare and MedTech. Board-level expertise, C-suite and senior roles in multinationals and SMEs in Medical Devices and Pharmaceuticals.
Jeremy Walsh
FCTO & Founder, Director
40 years + in MedTech. He led Tidalsense, developing N-Tidal, a transformational respiratory diagnostic device, secured £5M+ funding. Two NASDAQ IPOs.
Kevin Auton
Director of RAQA and Wellness
35 years + in Life Sciences and MedTech. Expert in regulatory affairs across UK, EU, and US healthcare markets. Secured £8m funding.
Paul Durbin
Software Lead
17 years + working with complex software systems. Previously at Public Health England and NHS Digital.
Prof. Anoop Chauhan MBE
Clinical Advisor
30 years + in Respiratory Medicine. R&I Executive Director at Portsmouth Hospitals NHS, Clinical Director of Technology Trials Unit.
Dr. Ajit Thomas
Clinical Investigator
20 years + in Respiratory Medicine. He leads the Sleep Clinic at Royal Stoke University Hospital. Chief investigator of SABRES exploratory clinical study
Development supported by:
Awarded two Smart grants to Apnea-Tech to test the feasibility of the team’s concept and then develop a first-generation device. This has resulted in the ApneScan DC1 and the SABRES clinical study at University Hospitals of North Midlands.
Keele University Business Bridge has supported Apnea-Tech in the development of the first generation apnoea and hypopnea identification algorithm.
Apnea-Tech has been supported by NIHR i4i FAST funding to explore with clinicians the importance of novel sleep apnoea metrics which can be delivered by its ApneScan device.
Centre for Process Innovation has supported Apnea-Tech in the development of its internal systems towards ISO 13485 standards.
Science Technologies Research Council funding is supporting the development of an SPO2 proxy from the ApneScan breath pathway signal. The development work is being completed by an AI team at IBM UK.
Diagnostics Development Hub (DxD Hub) is a national platform hosted by the Agency for Science, Technology and Research (A*STAR). Apnea-Tech are delighted to have them on board alongside the MedTech Catapult team in Singapore as a part of our product development programme.
Our ApneScan sleep apnoea diagnostic has been selected by MedTech Catapult, Singapore’s first dedicated MedTech productisation initiative as part of their programme. Supported by a £1.3m non dilutive development grant.
Enquiries
Apnea-Tech’s founders are actively seeking strategic partners to further refine and commercialise their affordable sleep apnoea screening and diagnostic solutions.